Here are five notes:
1. Dr. Laurencin received the award, the nation’s highest honor for achievement and leadership in advancing the field of technology, from President Barack Obama.
2. Dr. Laurencin is CEO of the Connecticut Institute for Clinical and Translational Science, director of the Institute for Regenerative Engineering and the Albert and Wilda Van Dusen Distinguished Endowed Chair Professor of Orthopaedic Surgery at UConn Health in Farmington.
3. Dr. Laurencin is an elected member of the Institute of Medicine of the National Academy of Sciences and the National Academy of Engineering.
4. His research centers on tissue engineering, biomaterials science, nanotechnology and stem cell science and regenerative engineering, a new field.
5. He completed his sports medicine and shoulder surgery fellowship at Cornell University in Ithaca, N.Y.
More articles on orthopedics:
Orthopedic surgeon to know: Dr. Richard Schaefer of Johns Hopkins Medicine
Dr. Kenneth Kearns joins Philadelphia Hand Center: 4 notes
Misinformation & mismanagement surrounds hip fracture patients’ osteoporosis risk — 6 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
